Purpose: Use of a nonmedical, catalogue type vacuum erection device resulted in a case of vacuum induced vasculogenic impotence and Peyronie’s disease.
Physical examination revealed a dorsal mid shaft Peyronie’s plaque. Nocturnal penile tumescence testing and ofice injection testing were abnormal and demonstrated partial, short- lived, dorsally curved erections. Dynamic pharmaco-cavenosometry and pharmaco-cavernosog- raphy established vasculogenic impotence with site-specific crural (unrelated to the Peyronie’s plaque veno-occlusive dysfunction and dorsal penile curvature
Click here for more information.
Study: Focused Shockwave as an Alternative to Medication for Erectile Dysfunction
ED affects millions of men worldwide, and while medications like sildenafil can provide temporary relief, they don’t address the underlying causes of the condition. That’s where low-intensity extracorporeal shockwave therapy (Li-ESWT), also known as focused shockwave therapy comes in. This non-invasive treatment has shown lasting results in improving erectile function and overall satisfaction in patients, offering a potential alternative to medications.
Visit www.vennhealthcare.com for more information.
Can low-intensity extracorporeal shockwave therapy improve erectile dysfunction? A prospective, randomized, double-blind, placebo- controlled study
Erectile dysfunction is a male sexual dysfunction defined as a consistent or recurrent inability to attain or maintain an erection sufficient for sexual intercourse. Erectile dysfunction is a common disorder of middle-aged men that pro- foundly affects their quality of life. For the past 15 years, oral treatment with phosphodiesterase-5 (PDE-5) inhibitors or intracavernosal injection therapy with vasodilat- ing agents has been the preferred treatment for erectile dys- function.
Click here for more information.
Evaluation of clinical efficacy, safety and patient satisfaction rate after low-intensity extracorporeal shockwave therapy for the treatment of male erectile dysfunction: an Australian first open-label single-arm prospective clinical trial
To evaluate the efficacy, safety and patient satisfaction rate with low-intensity extracorporeal shockwave therapy (LiESWT) in Australian men with erectile dysfunction (ED), as LiESWT induces neovascularisation and potentially enhances penile perfusion and improves erectile function.
Click here for more information.
Clinical studies on low intensity extracorporeal shockwave therapy for erectile dysfunction: a systematic review and meta-analysis of randomised controlled trials
The efficacy of low intensity extracorporeal shock wave therapy (LI-ESWT) for erectile dysfunction (ED) has received hard criticism and recently published meta-analyses were not able to provide further insights, nor specific recommendations.
Click here for more information.
A systematic review of the long-term efficacy of low-intensity shockwave therapy for vasculogenic erectile dysfunction
Atherosclerosis of penile arteries and endothelial dysfunction, known as vasculogenic erectile dysfunction (ED), is the cause of ED in 40% of men over the age of fifty. There is cur- rently no known long-lasting or curative treatment for vascu- logenic ED.
Click here for more information.
